• 7871 Citations
  • 25 h-Index
20012019
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Marina Chiara Garassino is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 22 Similar Profiles
Non-Small Cell Lung Carcinoma Medicine & Life Sciences
docetaxel Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Platinum Medicine & Life Sciences
Survival Medicine & Life Sciences
Immunotherapy Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2001 2019

  • 7871 Citations
  • 25 h-Index
  • 132 Article
  • 13 Review article
  • 1 Letter
  • 1 Short survey
4 Citations (Scopus)

Association between antibiotic-immunotherapy exposure ratio and outcome in metastatic non small cell lung cancer

Galli, G., Triulzi, T., Proto, C., Signorelli, D., Imbimbo, M., Poggi, M., Fucà, G., Ganzinelli, M., Vitali, M., Palmieri, D., Tessari, A., de Braud, F., Garassino, M. C., Colombo, M. P. & Lo Russo, G., Jun 2019, In : Lung Cancer. 132, p. 72-78 7 p.

Research output: Contribution to journalArticle

Non-Small Cell Lung Carcinoma
Immunotherapy
Anti-Bacterial Agents
Disease-Free Survival
Survival
1 Citation (Scopus)

BRAF Mutant NSCLC and Immune Checkpoint Inhibitors: Results From a Real-World Experience

Rihawi, K., Giannarelli, D., Galetta, D., Delmonte, A., Giavarra, M., Turci, D., Garassino, M., Tiseo, M., Barbieri, F., Panni, S. & Ardizzoni, A., Mar 2019, In : Journal of Thoracic Oncology. 14, 3, p. e57-e59

Research output: Contribution to journalLetter

Characterization of patients with metastatic non-small-cell lung cancer obtaining long-term benefit from immunotherapy

Galli, G., Proto, C., Signorelli, D., Imbimbo, M., Ferrara, R., Prelaj, A., De Toma, A., Ganzinelli, M., Zilembo, N., De Braud, F., Garassino, M. C. & Lo Russo, G., Aug 2019, In : Future Oncology. 15, 23, p. 2743-2757 15 p.

Research output: Contribution to journalArticle

Non-Small Cell Lung Carcinoma
Immunotherapy
Multivariate Analysis
7 Citations (Scopus)

Choosing wisely first line immunotherapy in non-small cell lung cancer (NSCLC): what to add and what to leave out

Proto, C., Ferrara, R., Signorelli, D., Lo Russo, G., Galli, G., Imbimbo, M., Prelaj, A., Zilembo, N., Ganzinelli, M., Pallavicini, L. M., De Simone, I., Colombo, M. P., Sica, A., Torri, V. & Garassino, M. C., May 2019, In : Cancer Treatment Reviews. 75, p. 39-51 13 p.

Research output: Contribution to journalReview article

Non-Small Cell Lung Carcinoma
Immunotherapy
Platinum
Tumor Burden
Drug Therapy
13 Citations (Scopus)

Circulating miRNAs and PD-L1 tumor expression are associated with survival in advanced NSCLC patients treated with immunotherapy: A prospective study

Boeri, M., Milione, M., Proto, C., Signorelli, D., Russo, G. L., Galeone, C., Verri, C., Mensah, M., Centonze, G., Martinetti, A., Sottotetti, E., Pastorino, U., Garassino, M. C. & Sozzi, G., Apr 1 2019, In : Clinical Cancer Research. 25, 7, p. 2166-2173 8 p.

Research output: Contribution to journalReview article

MicroRNAs
Non-Small Cell Lung Carcinoma
Immunotherapy
Prospective Studies
Survival